11/21
05:30 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) was upgraded by analysts at Chardan Capital to a "strong-buy" rating.
11/18
09:50 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
11/18
09:50 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
11/13
10:43 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
11/13
10:43 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
11/7
01:48 pm
cnta
Rating for CNTA
Low
Report
Rating for CNTA
11/7
01:48 pm
cnta
Rating for CNTA
Low
Report
Rating for CNTA
10/28
06:09 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
10/28
05:06 am
cnta
Centessa initiated with an Overweight at Stephens
Low
Report
Centessa initiated with an Overweight at Stephens
10/28
05:06 am
cnta
Centessa initiated with an Overweight at Stephens
Low
Report
Centessa initiated with an Overweight at Stephens
10/6
09:15 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $28.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $28.00 price target on the stock.
10/6
09:15 am
cnta
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $28.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals (NASDAQ:CNTA) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $28.00 price target on the stock.
10/6
09:13 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA
10/6
09:13 am
cnta
Rating for CNTA
Low
Report
Rating for CNTA